Zoryve Cream
Product Images NDC 80610-115

8 FDA label images from Arcutis Biotherapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zoryve (NDC 80610-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Arcutis Biotherapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Roflumilast 01)

Chemical Structure (Roflumilast 01)
Chemical structure of roflumilast, the active ingredient in ZORYVE cream. The diagram shows the molecular arrangement including chlorine atoms, fluoromethoxy group, and pyridine ring in the compound.*
FDA Label Image

Figure 1 (Roflumilast 02)

Figure 1 (Roflumilast 02)
Two line graphs labeled DERMIS-1 and DERMIS-2 show the percentage of subjects with WI-NRS success over an 8-week period, comparing roflumilast 0.3% cream to vehicle cream. Both graphs display a higher percentage of success with roflumilast 0.3% compared to vehicle cream at each time point from baseline to week 8.*
FDA Label Image

Figure 2 (Roflumilast 03)

Figure 2 (Roflumilast 03)
Packaging label for ZORYVE (roflumilast) cream 0.3%, a topical prescription drug by Arcutis Biotherapeutics, Inc. The carton indicates a 60 g net weight and specifies the product is for topical use only, not for oral, ophthalmic, or intravaginal use. The label displays storage instructions and a list of inactive ingredients, emphasizing the active strength of 3 mg per gram (0.3%) roflumilast in cream form.*
FDA Label Image

Figure 3 (Roflumilast 04)

Figure 3 (Roflumilast 04)
Two line graphs titled INTEGUMENT-1 and INTEGUMENT-2 showing the percentage of subjects with WI-NRS success over baseline, Week 1, Week 2, Week 3, and Week 4. Both compare ZORYVE cream 0.15% (solid line with circles) to a vehicle cream (dotted line with squares), depicting higher percentages for ZORYVE cream at each time point.*
FDA Label Image

Figure 4 (Roflumilast 05)

Figure 4 (Roflumilast 05)
A line graph comparing the percentage of subjects with a positive VIGA-AD response over four weeks between ZORYVE cream 0.05% and vehicle cream in pediatric subjects. The graph shows a higher success rate with ZORYVE cream over time compared to vehicle cream.*
FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
Carton packaging label for ZORYVE (roflumilast) cream 0.3%, a topical prescription drug by Arcutis Biotherapeutics, Inc. The 60 g cream is specified for topical use only, not for oral, ophthalmic, or intravaginal use. Label includes storage instructions, ingredient list, dosage recommendation reference, and barcode. The design features blue and orange diagonal stripes with text in blue and black.*
FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
Packaging label for ZORYVE (roflumilast) cream 0.15%, a topical prescription cream by Arcutis Biotherapeutics, Inc. The label indicates the net weight of 60 grams and specifies use for topical application only, not for oral, ophthalmic, or intravaginal use. The label also includes storage instructions, ingredients, and a barcode.*
FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
Packaging label for ZORYVE (roflumilast) cream 0.05%, a topical prescription drug. The label shows the product name, strength (0.05%), route of administration (topical use only), net weight of 60 g, and the labeler Arcutis Biotherapeutics, Inc. It includes storage instructions, warnings to keep out of reach of children, and a list of cream ingredients. The design features a green and orange diagonal color block and multiple instances of the product name and strength.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.